Online Video Library Launched To Share Martha Beck's Experience Living with Fibromyalgia
- Details
- Category: Eli Lilly and Company
For people living with painful conditions, September is a time for their true stories of triumph to emerge. Helping to foster support and communication, National Pain Awareness Month allows people with painful conditions to educate others about their experiences, build connections and together fight their pain.
Abbott Again Named One of the 'Best Places to Launch a Career' by BusinessWeek
- Details
- Category: Abbott
For the fourth consecutive year, Abbott (NYSE: ABT) has been named one of the "50 Best Places to Launch a Career" by BusinessWeek magazine. The list highlights companies that excel at offering a superior workplace for entry-level employees. This year, Abbott moved up to No. 13, and was once again the top-ranked health care company on the list.
Shantha Biotechnics Awarded Large Vaccine Contracts by United Nations Agency
- Details
- Category: Sanofi
Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT : SAN and NYSE : SNY), announced that Shantha Biotechnics was awarded contracts by a United Nations agency for supplies of pentavalent vaccine SHAN5™ (combination vaccine of Diphtheria, Pertussis, Tetanus, Haemophilus influenza B, and Hepatitis B). The contracts, worth $340 million, cover the period 2010-2012.
Roche recognised as new Super Sector Leader in Dow Jones Sustainability Index
- Details
- Category: Roche
Roche (SIX: RO, ROG; OTCQX: RHHBY) has been rated as the new Super Sector Leader in Healthcare on the Dow Jones Sustainability Index, placing Roche as the most sustainable healthcare company worldwide.
Novartis MF59® vaccine shows strong immune response in A(H1N1) clinical trials
- Details
- Category: Novartis
A pilot trial of Novartis adjuvanted cell culture-based A(H1N1) vaccine[1] indicates that the "swine flu" vaccine elicited a strong immune response and was well tolerated. The trial was run by the UK's University of Leicester and University Hospitals of Leicester.
Abbott to Acquire Visiogen, Expanding Vision Care Portfolio
- Details
- Category: Abbott
Abbott (NYSE: ABT) has announced a definitive agreement to acquire Visiogen, Inc. for $400 million in cash, providing the company with a next-generation accommodating intraocular lens (IOL) technology to address presbyopia for cataract patients.
Bayer Acquires Two Prescription Dermatology Product Lines from SkinMedica in the U.S.
- Details
- Category: Bayer
Intendis GmbH, which is part of Bayer HealthCare, has signed an agreement to acquire two prescription dermatology product lines from SkinMedica, Inc., a dermatology company based in Carlsbad, CA, USA.
More Pharma News ...
- Pfizer Concludes Previously Disclosed Settlement Agreement with U.S. Department of Justice
- New Analysis of the Pfizer-Sponsored TNT Clinical Trial
- Abbott Launches Next-Generation XIENCE PRIME(TM) Drug Eluting Stent in International Markets
- Phase III Head to Head Trial Showed Ticagrelor Reduced Cardiovascular Death and Heart Attacks
- Bayer Completes Enrollment into Major Phase III Study with Rivaroxaban (ROCKET AF)
- Bayer Completes Enrollment into Major Phase III Study with Rivaroxaban
- Studies Published in The Lancet Show Roflumilast Improves Lung Function and Reduces Exacerbations